Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial

Mehmet Altan, Yan Wang, Juhee Song, James Welsh, Chad Tang, Nandita Guha-Thakurta, George R. Blumenschein, Brett W. Carter, Jeffrey S. Wefel, Amol J. Ghia, Debra N. Yeboa, Mary Frances Mcaleer, Caroline Chung, Kristina Demas Woodhouse, Susan L. Mcgovern, Chenyang Wang, Betty Y.S. Kim, Jeffrey S. Weinberg, Tina M. Briere, Yasir Y. ElaminXiuning Lee, Tina Cascone, Marcelo V. Negrao, Ferdinandos Skoulidis, Renata Ferrarotto, John V. Heymach, Jing Li

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences